FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to RGD-bacteriochlorophyll conjugates which are targeted into domains of tumour necrosis and collected therein much longer than in non-necrotic domains to be used in the minimally invasive tumour-targeted imaging, tumour-targeted photodynamic therapy and/or interactive prediction of necrotic tumours.
EFFECT: improving tumour imaging.
16 cl, 38 ex, 34 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATE OF RGD-PEPTIDES AND PHOTOSENSITISERS OF PORPHYRIN OR (BACTERIO)CHLOROPHYLL AND APPLICATION THEREOF | 2007 |
|
RU2450018C2 |
| RGD-CONTAINING PEPTIDOMIMETICS AND THEIR APPLICATION | 2009 |
|
RU2519736C2 |
| COMBINED METHODS OF THERAPY FOR TREATMENT OF CANCEROUS TUMORS | 2017 |
|
RU2747258C2 |
| OPTICAL AGENTS OF VISUALISATION | 2008 |
|
RU2475266C2 |
| WATER-SOLUBLE ANION-CONTAINING BACTERIOCHLOROPHYLL DERIVATIVES OF AND THEIR APPLICATION | 2003 |
|
RU2353624C2 |
| TARGETED EXPOSURE TO TRASTUZUMAB-RESISTANT HER2+ BREAST CANCER BY HER3-TARGETED NANOPARTICLES | 2015 |
|
RU2692104C2 |
| CATIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND USE THEREOF | 2005 |
|
RU2397172C2 |
| ANTI-HER3 ANTIBODY-DRUG CONJUGATE | 2015 |
|
RU2711640C2 |
| PHOTOSENSIBILIZERS BASED ON (BACTERIO)CHLOROPHYLL FOR TREATMENT OF EYE DISEASES AND DISORDERS | 2012 |
|
RU2632439C2 |
| SONODYNAMIC THERAPY | 2016 |
|
RU2791572C1 |
